Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol.
Publication
, Journal Article
Bowen, PH; Guyton, JR
Published in: Curr Atheroscler Rep
January 2000
Low levels of high-density lipoprotein cholesterol (HDL-C) constitute a strong risk factor for developing coronary heart disease. This risk can be decreased by even slight improvements in HDL-C levels. This review discusses both pharmacologic and nonpharmacologic treatments of patients with low levels of HDL-C, including lifestyle modifications and the benefits of oral estrogens, niacin, fibrates, statins, and combination drug therapy.
Duke Scholars
Published In
Curr Atheroscler Rep
DOI
ISSN
1523-3804
Publication Date
January 2000
Volume
2
Issue
1
Start / End Page
58 / 63
Location
United States
Related Subject Headings
- Risk Factors
- Niacin
- Life Style
- Hypolipidemic Agents
- Humans
- Exercise
- Estrogens
- Coronary Disease
- Cholesterol, HDL
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bowen, P. H., & Guyton, J. R. (2000). Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol. Curr Atheroscler Rep, 2(1), 58–63. https://doi.org/10.1007/s11883-000-0095-z
Bowen, P. H., and J. R. Guyton. “Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol.” Curr Atheroscler Rep 2, no. 1 (January 2000): 58–63. https://doi.org/10.1007/s11883-000-0095-z.
Bowen PH, Guyton JR. Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol. Curr Atheroscler Rep. 2000 Jan;2(1):58–63.
Bowen, P. H., and J. R. Guyton. “Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol.” Curr Atheroscler Rep, vol. 2, no. 1, Jan. 2000, pp. 58–63. Pubmed, doi:10.1007/s11883-000-0095-z.
Bowen PH, Guyton JR. Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol. Curr Atheroscler Rep. 2000 Jan;2(1):58–63.
Published In
Curr Atheroscler Rep
DOI
ISSN
1523-3804
Publication Date
January 2000
Volume
2
Issue
1
Start / End Page
58 / 63
Location
United States
Related Subject Headings
- Risk Factors
- Niacin
- Life Style
- Hypolipidemic Agents
- Humans
- Exercise
- Estrogens
- Coronary Disease
- Cholesterol, HDL
- Cardiovascular System & Hematology